A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: awaiting (67), pending (44)

CarboplatinAUC4-Gemcitabine (day 1,8)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Regimen  Ovary-Carboplatin (AUC4)-Gemcitabine (
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabine-day18.pdf

Carboplatin (AUC4)-Gemcitabine (day 1) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday1Retreat.pdf

Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel(14) Ver1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXELACCELERATED Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (accelera
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel-14.pdf

Neratinib

Description
Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for hor
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

Papers Sept 2020 held in closed session due to Covid-19

Description
Date Time Location Chair Agenda - Trust Board Meeting 29/09/2020 9:00 - 16:00 Microsoft Teams Peter Hollins 1 Chair’s Welco
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/papers-sept-2020-held-in-closed-session-due-to-covid-19.pdf

ClofarabineCytarabine

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA ALL CLOFARABINE-CYTARABINE In-Patient Regimen Clofarabine not licensed in adult
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/ClofarabineCytarabine.pdf

RIPCORD Privacy Notice UHS v5

Description
This is a PRIVACY NOTICE for patients who took part in the RIPCORD 2 study Chief Investigator: Professor Nicholas Curzen
Url
/Media/Southampton-Clinical-Research/Downloads/RIPCORD-Privacy-Notice-UHS-v5.pdf

Vismodegib

Description
Chemotherapy Protocol BASAL CELL CARCINOMA (BCC) VISMODEGIB Regimen  BCC - Vismodegib Indication  The patient either has; a. Gorlin Syndrome w
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Vismodegib.pdf

Private patient policy

Description
Private Patient Policy Trust reference Description FIN002 Version number 2 This policy provides guidance on how to administer and account for p
Url
/Media/UHS-website-2019/Docs/Policies/Private-patient-policy.pdf

Bronchoscopy (surgical) - patient information

Description
This factsheet contains information about having a bronchoscopy (surgical).
Url
/Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Bronchoscopy-surgical-3130-PIL.pdf
631 to 640 of 1000
Previous … 62 63 64 65 66 … Next